International Stem Cell Corp (ISCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -95 | -214 | -131 | 327 | 458 |
| Depreciation Amortization | 99 | 49 | 194 | 146 | 99 |
| Accounts receivable | -236 | -58 | 173 | 103 | 85 |
| Accounts payable and accrued liabilities | 13 | -4 | 42 | -19 | 9 |
| Other Working Capital | -654 | -245 | -3 | -302 | -243 |
| Other Operating Activity | 703 | 279 | 654 | 513 | 298 |
| Operating Cash Flow | $-170 | $-193 | $929 | $768 | $706 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -128 | -8 | -80 | -80 | -66 |
| Purchase Sale Intangibles | N/A | -1 | -3 | N/A | N/A |
| Other Investing Activity | 0 | -1 | -3 | 0 | 0 |
| Investing Cash Flow | $-128 | $-9 | $-83 | $-80 | $-66 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | -9 | 0 | 0 | 0 |
| Financing Cash Flow | $N/A | $-9 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 1,588 | 1,588 | 742 | 742 | 742 |
| End Cash Position | 1,290 | 1,386 | 1,588 | 1,430 | 1,382 |
| Net Cash Flow | $-298 | $-202 | $846 | $688 | $640 |
| Free Cash Flow | |||||
| Operating Cash Flow | -170 | -193 | 929 | 768 | 706 |
| Capital Expenditure | -128 | -8 | -80 | -80 | -66 |
| Free Cash Flow | -298 | -201 | 849 | 688 | 640 |